Alpha DNA Investment Management’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-281
Closed -$35K 515
2021
Q1
$35K Sell
281
-2,208
-89% -$408K 0.04% 216
2020
Q4
$447K Buy
+2,489
New +$553K 0.48% 94

Other funds holding QDEL

Alpha DNA Investment Management's QDEL Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of QuidelOrtho (QDEL) in Q2 2021, closing a stake of 281 shares — an estimated $35K sold.

Alpha DNA Investment Management first reported a position in QDEL in Q4 2020 and held it in 2 quarters. The position peaked at $447K in Q4 2020. 330 funds tracked by Wall St. Rank hold QDEL as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining QuidelOrtho position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 281 QuidelOrtho shares in Q2 2021, an estimated $35K.
  • Alpha DNA Investment Management first reported a position in QuidelOrtho in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's QuidelOrtho position peaked at $447K in Q4 2020.
  • 330 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.